The Pharmacy Times® Brain Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to neural development, plasticity, functioning, and recovery associated with aging.
March 22nd 2023
Strong interprofessional team helps ensure safe transitions and minimize adverse events, medication errors
Clinical Overview: Lecanemab for the Treatment of Alzheimer DiseaseJanuary 30th 2023
Promising results for lecanemab's efficacy in patients with mild cognitive impairment or mild dementia associated with Alzheimer disease were accompanied by reports of adverse effects associated with treatment.
Artificial Intelligence Tool Reflects Risk of Cognitive Decline, Alzheimer Disease Based on Brain AgeJanuary 18th 2023
The model can predict the chronological ages of cognitively normal participants with an average absolute error of 2.3 years, which is about 1 year more accurate than an existing model.
Study Results Show Lower Mortality Risk With Nuplazid for Parkinson Disease PsychosisJanuary 11th 2023
Analysis indicates that Acadia Pharmaceuticals Inc’s pimavanserin is the only FDA-approved medication for the treatment of delusions and hallucinations associated with PDP.
Study Results Suggest Exercise, Mindfulness Do Not Boost Cognitive Function in Older AdultsDecember 19th 2022
Although physical activity and the practice of being present in the moment are associated with many benefits, analysis shows that neither led to measurable improvements in brain health.
Updated USPSTF Guidelines Show Benefits of Screening for Obstructive Sleep Apnea Do Not Outweigh HarmsDecember 9th 2022
The decision is updated from a 2017 recommendation to screen people for obstructive sleep apnea, which can lead to daytime sleepiness and other adverse outcomes.
Study: Black Adults Experienced Early Signs of Brain Aging Faster Than Other Racial, Ethnic Minority GroupsDecember 6th 2022
White adults in their midlife showed slower brain aging than Black and Latinx individuals, but between mid- and late life, they showed increased signs of aging.
Clinical Overview: Skysona for Early Cerebral AdrenoleukodystrophyNovember 10th 2022
Cerebral adrenoleukodystrophy is a progressive neurodegenerative disease causes irreversible neurologic decline and can result in functional disabilities, such hearing loss and cortical blindness.